Provides rapid lab-quality at-home molecular diagnostics for infectious diseases before its technology assets were acquired by Pfizer.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Lucira Health, Inc. operates as a medical technology enterprise that develops disposable molecular diagnostic tools for infectious disease testing. The company focuses on manufacturing instrument-free, single-use test kits that utilize nucleic acid amplification technology to deliver rapid and accurate results outside of traditional laboratory environments. By integrating complex laboratory processes into user-friendly hardware, its platform allows individuals to self-test for respiratory viral infections from the comfort of home.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Lucira Management Team
Investors
DCVC
Eclipse Ventures
Seraph Group
Shangbay Capital
Sunstone Capital A/S
Y Combinator
Lucira Valuations & Financials
View real-time NPM data on Lucira stock including daily Lucira stock price estimates, valuation history, and historical share price information. Access Lucira financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Lucira pricing across six independent market signals. Looking for private company due diligence data sources on Lucira? Get in touch to learn more.
Similar Companies
like Lucira
Podium
Enterprise Software
Customer messaging platform enabling companies to connect at critical touch points.
Manticore Games
Media & Entertainment
Independent developer of high quality multiplayer PC and console games and services.
Fazeshift
AI & Machine Learning
Enables finance teams to offload tedious AR tasks and improve cash flow with intelligent automation.
StockX
Commerce & Marketplaces
Online marketplace to buy and sell authentic sneakers, streetwear, handbags, and watches.
Rali
Enterprise Software
Drive transformation by leveraging AI, expert-led journeys, and a structured methodology to activate and sustain change across your organization.
Viz.ai
Healthcare & Life Sciences
Uses AI to analyze medical imaging data in real-time for faster diagnosis and treatment in neurovascular, cardiovascular and trauma care.
Indapta Therapeutics
Healthcare & Life Sciences
Develops NK cell-based immunotherapies that enhance the immune system to target and treat cancer.
Juniper Square
Enterprise Software
Software streamlining fundraising, investment administration, and investor reporting for the private funds industry.
Foundation Alloy
Industrials
Develops advanced alloys and manufacturing methods that produce high-performance metal components with faster development and improved efficiency.
FAQ
We have answers
Lucira stock does not trade on public stock exchanges. Lucira stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Lucira stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Lucira Stock does not trade on public stock exchanges. In order to sell Lucira shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Lucira does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Lucira share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for Lucira stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Lucira stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Lucira stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Lucira is a private company and has not had an IPO. There is currently no Lucira IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Lucira IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
